<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
	<channel>
		<title>Nanomedx news</title>
		<link>https://nanomedx.com.au/</link>
		<description>Announcements and updates from Nanomedx.</description>
		<language>en-AU</language>
		<item>
			<title>MRFF grant to take ApixaShield towards first-in-human trial</title>
			<link>https://nanomedx.com.au/news/mrff-grant-apixashield/</link>
			<guid isPermaLink="true">https://nanomedx.com.au/news/mrff-grant-apixashield/</guid>
			<pubDate>Sat, 01 Aug 2026 00:00:00 GMT</pubDate>
			<description>Nanomedx co-founder Dr Richard Tan will lead a $426,000 MRFF Early to Mid-Career Researchers grant advancing the ApixaShield valve coating toward a first-in-human trial</description>
		</item>
		<item>
			<title>TTRA Drugs and Devices awards Tranche A funding</title>
			<link>https://nanomedx.com.au/news/ttra-tranche-a-funding/</link>
			<guid isPermaLink="true">https://nanomedx.com.au/news/ttra-tranche-a-funding/</guid>
			<pubDate>Sat, 01 Nov 2025 00:00:00 GMT</pubDate>
			<description>Nanomedx secures $750,000 in TTRA funding to advance its peripheral artery disease therapy towards first-in-human trials</description>
		</item>
	</channel>
</rss>